Natixis’s Vaxart VXRT Stock Holding History

Natixis’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,310	Closed	-$42K	–	1362
2022 Q3	$42K	Buy	18,310 +810	+5%	+$2.79K	﹤0.01%	1011
2022 Q2	$62K	Sell	17,500 -5,108	-23%	-$19.1K	﹤0.01%	1067
2022 Q1	$114K	Buy	+22,608	New	+$115K	﹤0.01%	1121
2014 Q2	–	Sell	-1,427	Closed	-$96K	–	529
2014 Q1	$96K	Buy	+1,427	New	+$88.3K	﹤0.01%	456

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Natixis's VXRT Position: Q4 2022 in Review

Natixis sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 18,310 shares — an estimated $42K sold.

Natixis first reported a position in VXRT in Q1 2014 and held it in 4 quarters. The position peaked at $114K in Q1 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

Natixis reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
Natixis sold 18,310 Vaxart shares in Q4 2022, an estimated $42K.
Natixis first reported a position in Vaxart in Q1 2014 and held it in 4 quarters.
Natixis's Vaxart position peaked at $114K in Q1 2022.
132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.